EFFICACY AND SAFETY OF LOW MOLECULAR WEIGHT HEPARIN IN RENAL TRANSPLANTATION1

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

1989 • 164 citations

Primary renal graft thrombosis

1996 • 156 citations

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

1992 • 102 citations

Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin®) in the prophylaxis of thromboembolic complications of abdominal oncological surgery

1988 • 89 citations

The Thromboprophylactic Effect of a Low-Molecular-Weight Heparin (Fragmin) in Hip Fracture Surgery

1992 • 61 citations

Vascular complications in 400 consecutive renal allotransplants.

1982 • 58 citations

Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients

1996 • 41 citations

Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factor

1992 • 35 citations